Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus

Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus

Zika virus (ZIKV) is a significant public health concern due to the pathogen’s ability to be transmitted by either mosquito bite or sexual transmission, allowing spread to occur throughout the world. The potential consequences of ZIKV infection to human health, specifically neonates, necessitates th...

Full description

Bibliographic Details
Main Authors: Tara Steffen, Mariah Hassert, Stella G. Hoft, E. Taylor Stone, Jianfeng Zhang, Elizabeth Geerling, Brian T. Grimberg, M. Scot Roberts, Amelia K. Pinto, James D. Brien
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Vaccines
Subjects:
Zika virus vaccine
pre-clinical development
immune response
animal model
Online Access:https://www.mdpi.com/2076-393X/8/2/170

Internet

https://www.mdpi.com/2076-393X/8/2/170

Similar Items